Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
about
A critical review of recent developments in radiotherapy for non-small cell lung cancerMultidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy.Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer.Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.Optimal Radiation Therapy for Small Cell Lung Cancer.Charged-particle therapy in cancer: clinical uses and future perspectives.Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung CancerCons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer.The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer.Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung CancerRadiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: "MTD" or "ALARA"?Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.Quality of Life in Oncology.Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapyOptimized radiotherapy to improve clinical outcomes for locally advanced lung cancerAdvances in radiation therapy for thoracic malignancies
P2860
Q28079625-ADA15EB0-FC02-43B7-B49C-C70CE29785B4Q33583931-D9FC6C5A-162C-4166-8FDD-5C848DEEBF4FQ33645619-C273F084-DFE8-40CF-B099-CD41125A5A83Q33893840-DC0FD236-C27A-4626-A615-512AB208DB37Q36030323-26396FE1-3C2F-4A5A-AB12-D6C8E0C20062Q37597937-7EBE8792-41FC-4D10-8F55-79B57A0C62CAQ38678310-74BB7E9F-8F7C-4394-B50B-3123F8BFD970Q38732983-BF1C5B36-8886-44B6-BFF7-00555C5EDF4EQ38746213-AA2799E2-3461-4A87-BCA5-1EC3EF41C5DAQ39052564-2C04E830-7B04-4093-86BE-B03E7EBEED0BQ39510875-25DABF57-63A7-4153-BB24-5EA7D791ABF1Q40702169-F8C9B9E6-28C6-4628-B76C-DEA1AE767494Q41081663-57DB875F-E2CE-427A-BD2F-8CD8402893A4Q41455781-2340830A-94E0-4FAC-AB03-4B9651A8E54AQ41670890-C10755DC-A152-4878-BD68-4BDC5E1157AEQ42363788-7C3DAE25-9072-4262-BC4D-8DB2AD0B5C43Q47447980-DB03C835-CB06-4EEF-8D65-802BEA66E252Q47757777-FF18DEC4-D05E-4FBC-994C-40F073BC1E7FQ48707805-8584B971-9766-460E-A3CD-C1A21606F9FAQ50029573-917CD366-DF10-409E-A361-4458FC114902Q57172945-4E203BBC-29B6-4197-BBF9-7F46DB0B6AA2Q58786273-EB3CE459-1114-407B-A089-C59E3C1C092BQ58804844-0FEAC15F-C142-4668-B851-3EF9E5512F68
P2860
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@ast
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@en
type
label
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@ast
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@en
prefLabel
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@ast
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@en
P2093
P2860
P50
P1433
P1476
Quality of Life Analysis of a ...... 0617 Randomized Clinical Trial
@en
P2093
Benjamin Movsas
Christopher Koprowski
Douglas W Johnson
Gregory Masters
Jeff Michalski
Jeffrey Bradley
Jeffrey Sloan
John Schallenkamp
Rakesh Gaur
P2860
P304
P356
10.1001/JAMAONCOL.2015.3969
P577
2015-11-25T00:00:00Z